WGS Q1 2022 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q1 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$54M-16.0% YoY

Gross Profit

$6M10.4% margin

Operating Income

-$89M-165.6% margin

Net Income

-$77M-142.6% margin

EPS (Diluted)

$-8.71

QoQ Revenue Growth

-6.7%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$85M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$518M

Total Liabilities

$188M

Stockholders' Equity

$329M

Cash & Equivalents

$315M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$64M	-16.0%
Gross Profit	$6M	-$4M	+230.1%
Operating Income	-$89M	-$197M	+54.6%
Net Income	-$77M	-$192M	+59.9%

Revenue Segments

Diagnostic Test

$52M49%

Diagnostic Test, Third Party Insurance

$47M45%

Diagnostic Test, Institutional Customers

$4M4%

Product and Service, Other

$1M1%

Diagnostic Test, Self Pay

$1M1%